4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001000229-17-000012
CIK 0001000229operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:07 PM ET
Size
9.2 KB
Accession
0001000229-17-000012
Insider Transaction Report
Form 4
Transactions
- Tax Payment
Common Shares
2016-12-30$120.04/sh−2,857$342,954→ 97,334 total - Exercise/Conversion
Common Shares
2016-12-30+8,001→ 100,191 total - Exercise/Conversion
Restricted Performance Shares
2016-12-30−8,001→ 0 totalExercise: $0.00→ Common Shares (8,001 underlying)
Holdings
- 15,218(indirect: By 401(k))
Common Shares
Footnotes (1)
- [F1]The shares vesting were awarded as restricted performance shares in February 2014. As reported in the Form 4 filing on February 10, 2014 at the time the award was made, "The restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period and the shares shall fully vest if that criterion is met. If it is not met, then no shares shall vest and the award shall be forfeited." The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 30, 2016, at the conclusion of the performance period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:07 PM ET
- Size
- 9.2 KB